These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 10668522

  • 1. Disease modification in rheumatoid arthritis with leflunomide.
    Emery P.
    Scand J Rheumatol Suppl; 1999; 112():9-14. PubMed ID: 10668522
    [Abstract] [Full Text] [Related]

  • 2. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
    Sharp JT, Strand V, Leung H, Hurley F, Loew-Friedrich I.
    Arthritis Rheum; 2000 Mar; 43(3):495-505. PubMed ID: 10728741
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group.
    Strand V, Cohen S, Schiff M, Weaver A, Fleischmann R, Cannon G, Fox R, Moreland L, Olsen N, Furst D, Caldwell J, Kaine J, Sharp J, Hurley F, Loew-Friedrich I.
    Arch Intern Med; 1999 Nov 22; 159(21):2542-50. PubMed ID: 10573044
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Leflunomide in the treatment of rheumatoid arthritis.
    Li EK, Tam LS, Tomlinson B.
    Clin Ther; 2004 Apr 22; 26(4):447-59. PubMed ID: 15189743
    [Abstract] [Full Text] [Related]

  • 8. Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazine.
    Larsen A, Kvien TK, Schattenkirchner M, Rau R, Scott DL, Smolen JS, Rozman B, Westhovens R, Tikly M, Oed C, Rosenburg R, European Leflunomide Study Group.
    Scand J Rheumatol; 2001 Apr 22; 30(3):135-42. PubMed ID: 11469522
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine.
    Scott DL, Smolen JS, Kalden JR, van de Putte LB, Larsen A, Kvien TK, Schattenkirchner M, Nash P, Oed C, Loew-Friedrich I, European Leflunomide Study Group.
    Ann Rheum Dis; 2001 Oct 22; 60(10):913-23. PubMed ID: 11557646
    [Abstract] [Full Text] [Related]

  • 11. The effects of disease-modifying anti-rheumatic drugs on the Health Assessment Questionnaire score. Lessons from the leflunomide clinical trials database.
    Scott DL, Strand V.
    Rheumatology (Oxford); 2002 Aug 22; 41(8):899-909. PubMed ID: 12154207
    [Abstract] [Full Text] [Related]

  • 12. Leflunomide versus methotrexate: a comparison of the European and American experience.
    Schiff MH.
    Scand J Rheumatol Suppl; 1999 Aug 22; 112():31-5. PubMed ID: 10668525
    [Abstract] [Full Text] [Related]

  • 13. Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthritis.
    Goldenberg MM.
    Clin Ther; 1999 Nov 22; 21(11):1837-52; discussion 1821. PubMed ID: 10890256
    [Abstract] [Full Text] [Related]

  • 14. Leflunomide for treating rheumatoid arthritis.
    Osiri M, Shea B, Robinson V, Suarez-Almazor M, Strand V, Tugwell P, Wells G.
    Cochrane Database Syst Rev; 2003 Nov 22; 2002(1):CD002047. PubMed ID: 12535423
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.
    Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Larsen A, Loew-Friedrich I, Oed C, Rosenburg R.
    Lancet; 1999 Jan 23; 353(9149):259-66. PubMed ID: 9929017
    [Abstract] [Full Text] [Related]

  • 18. When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?
    Dougados M, Emery P, Lemmel EM, Zerbini CA, Brin S, van Riel P.
    Ann Rheum Dis; 2005 Jan 23; 64(1):44-51. PubMed ID: 15271770
    [Abstract] [Full Text] [Related]

  • 19. Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial.
    Kremer JM, Genovese MC, Cannon GW, Caldwell JR, Cush JJ, Furst DE, Luggen ME, Keystone E, Weisman MH, Bensen WM, Kaine JL, Ruderman EM, Coleman P, Curtis DL, Kopp EJ, Kantor SM, Waltuck J, Lindsley HB, Markenson JA, Strand V, Crawford B, Fernando I, Simpson K, Bathon JM.
    Ann Intern Med; 2002 Nov 05; 137(9):726-33. PubMed ID: 12416946
    [Abstract] [Full Text] [Related]

  • 20. Medical therapy: where are we now?
    Resman-Targoff BH.
    Am J Health Syst Pharm; 2006 Sep 15; 63(18 Suppl 4):S11-8. PubMed ID: 16960243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.